0

L-3,4-Dihydroxyphenylalanine methyl ester hydrochloride

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1421654
CAS1421-65-4
Structure
MDL NumberMFCD00038958
Molecular Weight247.68
InChI KeyWFGNJLMSYIJWII-FJXQXJEOSA-N
Descriptionsolid
Colorwhite to off-white
Formsolid
Size500MG, 1G, 5G
Storage Conditions−20°C
1

Effect of Chronic Treatment With Angiotensin Type 1 Receptor Antagonists on Striatal Dopamine Levels in Normal Rats and in a Rat Model of Parkinson's Disease Treated With L-DOPA

Antonio Dominguez-Meijide, Begoña Villar-Cheda, Pablo Garrido-Gil, German Sierrra-Paredes, Maria J Guerra, Jose L Labandeira-Garcia

Neuropharmacology. 2014 Jan;76 Pt A:156-68.

PMID: 23973568

1

Fictive Locomotion in the Adult Decerebrate and Spinal Mouse in Vivo

C F Meehan, L Grondahl, J B Nielsen, H Hultborn

J Physiol. 2012 Jan 15;590(2):289-300.

PMID: 22106172

1

Relative Potency and Efficacy of Some Dopamine Agonists With Varying Selectivities for D1 and D2 Receptors in MPTP-induced Hemiparkinsonian Monkeys

E F Domino, J Sheng

J Pharmacol Exp Ther. 1993 Jun;265(3):1387-91.

PMID: 8099621

1

Striatal Inhibition of PKA Prevents Levodopa-Induced Behavioural and Molecular Changes in the Hemiparkinsonian Rat

Manon Lebel, Laure Chagniel, Geneviève Bureau, Michel Cyr

Neurobiol Dis. 2010 Apr;38(1):59-67.

PMID: 20060905

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode